Clinical Trials List
2016-07-01 - 2020-12-31
Others
Terminated3
ICD-10C34
Malignant neoplasm of bronchus and lung
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- JIN-YUAN SHIH Division of Thoracic Medicine
- 許嘉林 Division of Thoracic Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 廖唯昱 Division of Thoracic Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- Jih-Hsiang Lee
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- 蔡子修 Division of Thoracic Medicine
- 林宗哲 Division of Hematology & Oncology
- 陳冠宇 Division of Thoracic Medicine
- 楊景堯 Division of Thoracic Medicine
- 林育麟 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- Yung-Hung Luo Division of Hematology & Oncology
- 賴信良 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- 蔡俊明 Division of Hematology & Oncology
- Heng-Sheng Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
4 Terminated
Audit
None
Taiwan National PI
Co-Principal Investigator
- Wen-Cheng Chang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- Chih-Hung Chen Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
3 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
400 participants
